Radius Health, Inc. (RDUS)
USD 29.06
(-0.03%)
USD 29.06
(-0.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 307.71 Million USD | -36.95% |
| 2022 | 488.07 Million USD | 7.7% |
| 2021 | 453.19 Million USD | 117.24% |
| 2020 | 208.61 Million USD | 32.68% |
| 2019 | 157.23 Million USD | 73.14% |
| 2018 | 90.81 Million USD | 337.02% |
| 2017 | 20.78 Million USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 307.71 Million USD | -36.95% |
| 2023 Q1 | 73.01 Million USD | 49.87% |
| 2023 Q2 | 95.92 Million USD | 31.38% |
| 2023 Q3 | 90.05 Million USD | -6.12% |
| 2023 Q4 | 39.47 Million USD | -56.16% |
| 2022 Q4 | 48.71 Million USD | -42.57% |
| 2022 Q1 | 38.89 Million USD | -34.9% |
| 2022 Q2 | 52.7 Million USD | 35.51% |
| 2022 FY | 488.07 Million USD | 7.7% |
| 2022 Q3 | 84.82 Million USD | 60.93% |
| 2021 Q2 | 47.2 Million USD | -9.46% |
| 2021 Q3 | 51.73 Million USD | 9.61% |
| 2021 Q4 | 59.74 Million USD | 15.48% |
| 2021 Q1 | 52.13 Million USD | -10.04% |
| 2021 FY | 453.19 Million USD | 117.24% |
| 2020 Q1 | 43.86 Million USD | -13.98% |
| 2020 Q3 | 73.78 Million USD | 60.96% |
| 2020 Q4 | 57.95 Million USD | -21.46% |
| 2020 FY | 208.61 Million USD | 32.68% |
| 2020 Q2 | 45.84 Million USD | 4.52% |
| 2019 Q1 | 26.61 Million USD | -15.46% |
| 2019 Q2 | 37.03 Million USD | 39.15% |
| 2019 Q4 | 50.98 Million USD | 19.7% |
| 2019 Q3 | 42.59 Million USD | 15.02% |
| 2019 FY | 157.23 Million USD | 73.14% |
| 2018 Q1 | 13.25 Million USD | 92.47% |
| 2018 FY | 90.81 Million USD | 337.02% |
| 2018 Q4 | 31.48 Million USD | 24.7% |
| 2018 Q3 | 25.24 Million USD | 21.22% |
| 2018 Q2 | 20.82 Million USD | 57.07% |
| 2017 FY | 20.78 Million USD | 0.0% |
| 2017 Q4 | 6.88 Million USD | -47.07% |
| 2017 Q3 | 13.01 Million USD | 1387.54% |
| 2017 Q2 | 875 Thousand USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 5.659% |
| Embecta Corp. | 749.9 Million USD | 58.966% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | -0.789% |
| Dynavax Technologies Corporation | 182.11 Million USD | -68.963% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -321.135% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 37.241% |
| PainReform Ltd. | -15 Thousand USD | 2051506.667% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -934.253% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -3589.947% |
| SCYNEXIS, Inc. | 124.51 Million USD | -147.124% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -55446.409% |
| Cosmos Health Inc. | 4.34 Million USD | -6974.517% |
| Journey Medical Corporation | 52.52 Million USD | -485.882% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -3589.947% |
| Safety Shot Inc | -74.45 Thousand USD | 413373.433% |
| Alpha Teknova, Inc. | 10.29 Million USD | -2888.646% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 28.543% |
| Bright Green Corporation | -237.01 Thousand USD | 129927.1% |
| Procaps Group, S.A. | 239.56 Million USD | -28.444% |
| Theratechnologies Inc. | 62.12 Million USD | -395.278% |
| Harrow Health, Inc. | 90.55 Million USD | -239.813% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -6384.953% |
| Biofrontera Inc. | 16.62 Million USD | -1750.671% |
| DURECT Corporation | 6.83 Million USD | -4404.626% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 41.248% |
| Cronos Group Inc. | 6.99 Million USD | -4301.596% |
| OptiNose, Inc. | 62.35 Million USD | -393.49% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 30.25% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 101654.785% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -9975.101% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 0.671% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -5604.144% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -818.927% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -2953.331% |
| ProPhase Labs, Inc. | 16.23 Million USD | -1794.889% |
| Phibro Animal Health Corporation | 312.48 Million USD | 1.528% |
| Procaps Group S.A. | 239.56 Million USD | -28.444% |
| Alvotech | -69.42 Million USD | 543.247% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -23533.717% |
| Viatris Inc. | 6.43 Billion USD | 95.221% |
| Rockwell Medical, Inc. | 8.7 Million USD | -3435.283% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -463.718% |
| SIGA Technologies, Inc. | 122.09 Million USD | -152.032% |
| Tilray Brands, Inc. | 223.35 Million USD | -37.77% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -635.271% |
| Shineco, Inc. | 882.16 Thousand USD | -34781.224% |
| PetIQ, Inc. | 252.74 Million USD | -21.75% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 41370.916% |
| Incannex Healthcare Limited | 12 Thousand USD | -2564158.333% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 83.344% |
| Alimera Sciences, Inc. | 61.17 Million USD | -403.042% |
| Silver Spike Investment Corp. | 8.1 Million USD | -3697.683% |
| Assertio Holdings, Inc. | 125.04 Million USD | -146.072% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 4517953.472% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -7241.891% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -4593.578% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 12867.159% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -1034.753% |
| Hempacco Co., Inc. | -1.21 Million USD | 25408.657% |
| Talphera, Inc. | -4.89 Million USD | 6386.231% |
| Alvotech | -69.42 Million USD | 543.247% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -38.812% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 56.633% |
| Currenc Group, Inc. | 17.35 Million USD | -1672.906% |
| Kamada Ltd. | 52.59 Million USD | -485.083% |
| Indivior PLC | 907 Million USD | 66.074% |
| Evoke Pharma, Inc. | 4.97 Million USD | -6080.486% |
| Flora Growth Corp. | 17.73 Million USD | -1634.756% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 12867.159% |
| Evolus, Inc. | 140.52 Million USD | -118.971% |
| HUTCHMED (China) Limited | 453.55 Million USD | 32.155% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 10.541% |
| Akanda Corp. | 111.44 Thousand USD | -276000.279% |